People · Operator
Named in public records as an officer, director or promoter · active 2016–2022 · Biotechnology, Other Technology
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Spinal Singularity, Inc. | — | Biotechnology | Seed | $4.9M | $88.6M | 2016 |
| Single Pass, Inc. | — | Other Technology | Pre-Seed | $460K | $7.1M | 2022 |
Bill Colone at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Bill Colone on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| David Ferrera | 1 | 4 |
| Kenneth Baker | 1 | 3 |
| Andrew Gilbert | 1 | 2 |
| Christopher Jennings | 1 | 2 |
| Derek Herrera | 1 | 2 |
| David Kaysen | 1 | 2 |
| Shahin Enayati | 1 | 1 |
| John Zehren | 1 | 1 |
| Dr.Peter Sunenshine | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.